Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes.

Correction of ADAMTS13 deficiency by in utero gene transfer of lentiviral vector encoding ADAMTS13 genes.
复制标题

DOI:
10.1038/mt.2008.223
复制
发表时间:
2009-01
期刊:
影响因子:
12.4
通讯作者:
Zheng, X. Long
Zheng, X. Long
中科院分区:
医学1区
文献类型:
--
作者:
Niiya, Masami;Endo, Masayuki;Shang, Dezhi;Zoltick, Philip W.;Muvarak, Nidal E.;Cao, Wenjing;Jin, Sheng-Yu;Skipwith, Christopher G.;Motto, David G.;Flake, Alan W.;Zheng, X. Long

文献摘要

参考文献

被引文献

相似文献

Deficiency of ADAMTS13 results in thrombotic thrombocytopenic purpura (TTP). Plasma infusion or exchange is the only effective treatment to date. We show in the present study that an administration of a self-inactivating lentiviral vector encoding human full-length ADAMTS13 and a variant truncated after the spacer domain (MDTCS) in mice by in utero injection at embryonic days 8 and 14 resulted in detectable plasma proteolytic activity (~5–70%), which persisted for the length of the study (up to 24 weeks). Intravascular injection via a vitelline vein at E14 was associated with significantly lower rate of fetal loss than intra-amniotic injection, suggesting that the administration of vector at E14 may be a preferred gestational age for vector delivery. The mice expressing ADAMTS13 and MDTCS exhibited reduced sizes of von Willebrand factor compared to the Adamts13−/− mice expressing eGFP. Moreover, the mice expressing both ADAMTS13 and MDTCS showed a significant prolongation of ferric chloride-induced carotid arterial occlusion time as compared to the Adamts13−/− expressing eGFP. The data demonstrate the successful correction of the prothrombotic phenotypes in Adamts13−/− mice by a single in utero injection of lentiviral vectors encoding human ADAMTS13 genes, providing the basis for developing a gene therapy for hereditary TTP in humans.
DOI: 10.1182/blood.v89.9.3097
发表时间: 1997-05-01
期刊: BLOOD
影响因子: 20.3
作者:
Furlan, M;Robles, R;Lammle, B
通讯作者: Lammle, B
DOI: 10.1182/blood-2005-07-2765
发表时间: 2006-04-15
期刊: BLOOD
影响因子: 20.3
作者:
Banno, F;Kokame, K;Miyata, T
通讯作者: Miyata, T
DOI: 10.1111/j.1538-7836.2005.01561.x
发表时间: 2005-11-01
影响因子: 10.4
作者:
Liu, L;Choi, H;Dong, JF
通讯作者: Dong, JF
DOI: 10.1038/sj.mt.6300332
发表时间: 2008-01-01
期刊: MOLECULAR THERAPY
影响因子: 12.4
作者:
Endo, Masayuki;Zoltick, Philip W.;Flake, Alan W.
通讯作者: Flake, Alan W.
DOI: 10.1046/j.1537-2995.1992.32893032096.x
发表时间: 1992-10-01
期刊: TRANSFUSION
影响因子: 2.9
作者:
ROCK, G;SHUMAK, K;SUTTON, DMC
通讯作者: SUTTON, DMC